Association between phthalate exposure and glutathione S-transferase M1 polymorphism in adenomyosis, leiomyoma and endometriosis
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Phthalates are known to have estrogenic effects in cell models and experimental animals. However, the evidence regarding the effects of phthalates on human reproduction is still limited. We conducted a case-control study to determine whether estrogen-dependent diseases are associated with phthalate exposure and how the glutathione S-transferase M1 (GSTM1; a major detoxification enzyme) genotype modulates the risk. METHODS: We recruited subjects who underwent laparotomy and had pathologic confirmation of endometriosis (EN) (n = 28), adenomyosis (AD) (n = 16) and leiomyoma (LEI) (n = 36) from the Department of Obstetrics and Gynecology at a medical center in Taiwan between 2005 and 2007. Controls (n = 29) were patients without any of the three aforementioned gynecologic conditions. Urine samples were collected before surgery and analyzed for seven phthalate metabolites using liquid chromatography-tandem mass spectrometry. Peripheral lymphocytes were used for GSTM1 genotype determination. RESULTS: Patients with LEIs had significantly higher levels of total urinary mono-ethylhexyl phthalate (SigmaMEHP; 52.1 versus 18.9 microg/g creatinine, P < 0.05) than the controls, whereas patients with EN had an increased level of urinary mono-n-butyl phthalate (94.1 versus 58.0 microg/g creatinine, P < 0.05). Subjects with GSTM1 null genotype had significantly increased odds for AD relative to those with GSTM1 wild genotype [odds ratio (OR) = 5.30; 95% CI, 1.22-23.1], even after adjustment for age and phthalate exposure. Subjects who carried the GSTM1 null genotype and had a high urinary level of SigmaMEHP showed a significantly increased risk for AD (OR = 10.4; 95% CI, 1.26-85.0) and LEIs (OR = 5.93; 95% CI, 1.10-31.9) after adjustment for age, compared with those with GSTM1 wild-type and low urinary level of SigmaMEHP. CONCLUSIONS: These results suggest that both GSTM1 null and phthalate exposure are associated with AD and LEI. Larger studies are warranted to investigate potential interaction between GSTM1 null and phthalate exposure in the etiology of estrogen-dependent gynecologic conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
The Epidemiology of Endometriosis
CRAMER, D. W., & MISSMER, S. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02761.x · Cited by 539
Adenomyosis, epidemiological factors
Vercellini, P., Viganò, P., Somigliana, E., Daguati, R., Abbiati, A., & Fedele, L. (2006) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2006.01.017 · Cited by 319 · cited 2×
“In the present study, we found that BMI and age are potential risk factors for EN and AD/LEI, respectively, which is consistent with previous studies (Cramer and Missmer, 2002; Vercellini et al., 2006), whereas other demographic characteristics, such as age at .”
ResultEngel, S. M., Zhu, C., Berkowitz, G. S., Calafat, A. M., Silva, M. J., Miodovnik, A., & Wolff, M. S. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.04.001 · Cited by 202
Cited by
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
State-of-the-science of endocrine disrupting chemicals, 2012
Bergman, Å., Heindel, J., Jobling, S., Kidd, K., & Zoeller, R. T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.020 · Cited by 1,388
The effects of phthalate ester exposure on human health: A review
Chang, W.-H., Herianto, S., Lee, C.-C., Hung, H., & Chen, H.-L. (2021) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.147371 · Cited by 398
Reproductive and developmental effects of phthalate diesters in females
Kay, V. R., Chambers, C., & Foster, W. G. (2013) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.766149 · Cited by 396
Environmental Endocrine-Disrupting Chemical Exposure: Role in Non-Communicable Diseases
Kumar, M., Sarma, D. K., Shubham, S., Kumawat, M., Verma, V., Prakash, A., & Tiwari, R. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.553850 · Cited by 391
Pathogenesis of uterine adenomyosis, invagination or metaplasia?
García-Solares, J., Donnez, J., Donnez, O., & Dolmans, M.-M. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.12.030 · Cited by 339
Epidemiology of Uterine Fibroids: From Menarche to Menopause
WISE, L. A., & LAUGHLIN-TOMMASO, S. K. (2016) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000164 · Cited by 339
The effects of phthalates in the cardiovascular and reproductive systems: A review
Mariana, M., Feiteiro, J., Verde, I., & Cairrao, E. (2016) · Environment International · doi:10.1016/j.envint.2016.07.004 · Cited by 332
Adenomyosis: Mechanisms and Pathogenesis
Zhai, J., Vannuccini, S., Petraglia, F., & Giudice, L. C. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1716687 · Cited by 292
Cohort Profile: The Dongfeng–Tongji cohort study of retired workers
Wang, F., Zhu, J., Yao, P., Li, X., He, M., Liu, Y., Yuan, J., Chen, W., Zhou, L., Min, X., et al. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys053 · Cited by 286
Self-citationPhthalates and risk of endometriosis
Upson, K., Sathyanarayana, S., De Roos, A. J., Thompson, M. L., Scholes, D., Dills, R., & Holt, V. L. (2013) · Environmental Research · doi:10.1016/j.envres.2013.07.003 · Cited by 157
Piazza, M. J., & Urbanetz, A. A. (2019) · JBRA Assisted Reproduction · doi:10.5935/1518-0557.20190016 · Cited by 90
Polymorphisms and endometriosis: A systematic review and meta-analyses
Méar, L., Herr, M., Fauconnier, A., Pineau, C., & Vialard, F. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmz034 · Cited by 85
Tobacco smoking and risk of endometriosis: a systematic review and meta-analysis
Bravi, F., Parazzini, F., Cipriani, S., Chiaffarino, F., Ricci, E., Chiantera, V., Viganò, P., & La Vecchia, C. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006325 · Cited by 80
Association between Phthalate Metabolites and Risk of Endometriosis: A Meta-Analysis
Cai, W., Yang, J., Liu, Y., Bi, Y., & Wang, H. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193678 · Cited by 55
“But the effects of phthalates on humans, especially reproductive development, are unproven [30,38].”
Background
Metadata
- Authors
- Huang, P.-C., Tsai, E.-M., Li, W.-F., Liao, P.-C., Chung, M.-C., Wang, Y.-H., & Wang, S.-L.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02-10
- Volume
- 25
- Issue
- 4
- Pages
- 986-994
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2147260640
- Cited by
- 148
- References
- 4
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.